Identification of a region within SEL1L protein required for tumour growth inhibition

Monica Cattaneo1, Cristina Canton, Alberto Albertini

  • 1Institute for Biomedical Technologies (National Research Council), Milan, Italy.

Gene
|January 20, 2004
PubMed

Insights

The SEL1L gene suppresses breast cancer cell growth. A specific region (amino acids 659-794) is crucial for this tumor-suppressing activity, containing key functional domains.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The SEL1L gene's role in suppressing breast cancer proliferation and aggression is known.
  • The precise mechanism and functional domains of SEL1L responsible for these effects are not fully understood.

Purpose of the Study:

  • To identify specific regions within SEL1L that confer antiproliferative properties.
  • To elucidate the molecular mechanisms underlying SEL1L's tumor-suppressing activity in breast cancer.

Main Methods:

  • Utilizing deletion mutants of SEL1L to assess functional domains.
  • Analyzing the impact of SEL1L expression on the proliferation and aggressive behavior of MCF-7 breast carcinoma cells.

Main Results:

  • Ectopic expression of full-length SEL1L significantly reduced MCF-7 cell proliferation and aggressiveness.
  • A specific region of SEL1L (amino acid residues 659-794) was identified as critical for suppressing tumor cell growth.
  • This functionally relevant domain contains the Hrd3 motif, a tetratricopeptide (TPR)-like SEL1 repeat, a transmembrane region, and a proline-rich tail.

Conclusions:

  • The SEL1L region between amino acids 659-794 is essential for its antiproliferative effects on breast cancer cells.
  • This domain likely mediates SEL1L's tumor-suppressing functions through its unique structural motifs.